Actinium Pharmaceuticals

ATNMNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$25.018 M

$0.80 +1.32%

Close of 7 Aug 2026

Revenue

$90.0K

#3614 by revenue

Earnings

-$33.9M

Loss-making

Shares outstanding

31,441,436

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#382Actuate TherapeuticsACTU$26.4M
#383Aytu BiopharmaAYTU$25.3M
#384Actinium PharmaceuticalsATNM$25.0M
#385IGC PharmaIGC$24.6M
#386Barinthus BiotherapeuticsBRNS$24.5M

Where these numbers come from

Share counts and financials for Actinium Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.